Chapter 2

Dr. Patel asked whether Richard could hear me.
“He’s upstairs with another woman.”
“Lock your door if you can.”
The urgency in his voice frightened me more than the original diagnosis. I turned the lock and lowered the phone volume.
A quality-control review at the pathology laboratory had discovered that two biopsy containers received duplicate tracking labels during transport. The slides attributed to me contained advanced pancreatic cancer, but a genetic comparison performed during the audit did not match the blood sample in my medical record.
“The malignant tissue is not yours,” Dr. Patel said.
I pressed one hand against my abdomen.
“Are you saying I don’t have cancer?”
“I’m saying the diagnosis cannot be yours. Your retained tissue sample is being reviewed now. Your scans always showed inflammation, but the biopsy result led us toward cancer. I need you back in the hospital tonight.”
“What do you think I have?”
“Possibly autoimmune pancreatitis. It can resemble pancreatic cancer on imaging, but it is often treatable. We cannot conclude anything until we repeat the testing.”
My breathing became shallow.
“Why did it take twelve days to find this?”
Another silence.
“The laboratory issued a preliminary correction notice ten days ago. Because the error involved chain-of-custody during specimen transport, the notice was also sent to the compliance office of the courier company.”
Whitmore Medical Logistics transported pathology samples for several Boston hospitals. Richard acquired the company two years earlier and made it one of his fastest-growing subsidiaries.
“Who received the notice?”
“A regulatory compliance director named Sienna Cross.”
The name struck harder than the diagnosis.
Dr. Patel explained that his office never received the original alert because someone at the laboratory incorrectly marked the incident as resolved by the courier. He discovered it only when a pathologist refused to certify another patient’s corrected result without notifying both physicians directly.
Sienna knew by Day Two that the terminal biopsy might not be mine.
On Day Twelve, she wore my robe and planned her nursery.
Dr. Patel arranged for a hospital transport under the explanation that my pain had worsened. I called Naomi Reed, the attorney who managed the Langford Family Trust my grandparents created. I told her only that Richard might be trying to obtain authority through documents I signed while heavily medicated.
“Do not sign anything else,” she said. “Photograph every page you can safely access.”
The black folder remained on my wheelchair tray. I photographed the signature pages with shaking hands.
One document appointed Richard as successor voting trustee. Another granted him a durable financial power of attorney. A third authorized the Whitmore Meridian board to treat him as the sole voting representative for the trust’s fifty-one-percent ownership interest.
The last document was a health-care proxy naming Richard as the person authorized to make decisions if I became incapacitated.
A do-not-resuscitate provision had been inserted behind it.
I had never agreed to one.
Richard knocked while I was speaking to Naomi.
“The transport is here.”
I slid the phone beneath my blanket and opened the door.
He studied my face. “What did the doctor want?”
“I told the office my pain was worse.”
His shoulders relaxed.
At the hospital, Dr. Patel admitted me under restricted privacy settings. Richard could confirm I was receiving care but could not access my results without my permission.
Repeat imaging and another biopsy followed. The waiting felt cruel, but it differed from the first diagnosis because fear was no longer the only possibility.
Three days later, Dr. Patel entered my room carrying a thin blue folder.
“No malignant cells,” he said.
The retained sample and repeat biopsy both supported autoimmune pancreatitis. Treatment would not be simple, but it was not a ninety-day death sentence. The steroids and immune therapy could control the inflammation. Much of my extreme weakness came from dehydration, untreated inflammation and sedating medication prescribed after the false terminal diagnosis.
I covered my face and cried until breathing hurt.
Relief arrived tangled with rage. Another patient had received my original label and therefore had not been told that her tissue showed advanced cancer. The hospital contacted her physician immediately, but twelve days of treatment time had been lost.
The original swap appeared accidental.
What happened afterward did not.
Dr. Patel placed a copy of the incident receipt on my table. Sienna’s electronic signature appeared beneath the correction notice.
Received and reviewed.
May you like
The timestamp was 9:14 a.m. on Day Two.
One hour later, Richard had emailed me the first draft of his business-continuity documents.